LeonaBio, Inc. Short-term Investments
LeonaBio, Inc. (LONA) had Short-term Investments of $18.74 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-14
- 2026-06-30: Short-term Investments $18.74M.
- 2026-03-31: Short-term Investments $34.85M.
- 2025-12-31: Short-term Investments $19.05M.
- 2025-09-30: Short-term Investments $4.35M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $18.74M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $34.85M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $19.05M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $4.35M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.25M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.84M 10-K · filed 2026-03-31 |
| 2024-06-30 | $17.94M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $44.27M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $56.84M 10-K · filed 2025-02-27 |
| 2023-09-30 | $62.61M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $72.46M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $80.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $104.38M 10-K · filed 2024-02-22 |
| 2022-09-30 | $133.91M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $157.35M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $145.72M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $143.22M 10-K · filed 2023-03-23 |
| 2021-09-30 | $128.45M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $153.24M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $176.37M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $124.06M 10-K · filed 2022-03-28 |
| 2020-09-30 | $60.55M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |